Key points from article :
DERM is being deployed across five NHS Trusts, and has been cleared in the UK as a Class IIA medical device.
To see if it can support two week skin cancer referral laid out in NICE guidelines.
Company aims to reduce the number of dermatology appointments needed by more than 4,700.
According to Skin Analytics becomes the first and only AI-based dermatology technology to gain this status.
To recognise the most common malignant, pre-malignant and benign skin lesions, including melanoma.
A lens that can be attached to a smartphone, and an app that contains this software to assess a lesion.
London-based Skin Analytics aims to further support the NHS with outpatient demand in dermatology.
Rapid diagnostics has been identified as the biggest factor in cancer survival rates.
Skin Analytics’ QA/RA director James Hamlyn said "-especially in the light of the backlog created by COVID. AI can bridge this gap.”
